Atlas Trials

Evaluation of Safety and Efficacy of Patients With Four and More Symptomatic Brain Metastases of Melanoma

Clinical trial NCT03728465 · TERMINATED

Trial details

NCT number
NCT03728465
Sponsor
University Hospital Tuebingen
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic MelanomaBrain Metastases
Start date
2018-04-10
Primary completion
2021-01-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.